SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Seagen Inc. (SGEN) .
本页证实的标准:
- VALUE (10/100, 未通过) — 分析师共识目标价暗示当前价格存在下行风险 ($171.82, 24.9%).
- 分析师共识目标价 $171.82 (-24.9% 下行风险) — 分析师认为当前价格水平存在明显下行风险。
SharesGrow 综合评分： 47/100 其中 2/7 项标准通过。
SharesGrow 7-Criteria Score
✗
价值
10/100
Price-to-Earnings & upside
Proven by this page
✓
健康
100/100
Debt-to-Equity & liquidity
→ Health
估值概览 — SGEN
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率21.53
EV/EBITDA0.0
每股数据
EPS (TTM)$-3.30
每股账面价值$0.00
每股营收$10.63
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$171.82 (-24.9%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2013 |
$-0.51 |
$269.26M |
$-62.52M |
-23.2% |
| 2014 |
$-0.62 |
$286.76M |
$-76.14M |
-26.6% |
| 2015 |
$-0.93 |
$336.8M |
$-120.49M |
-35.8% |
| 2016 |
$-1.00 |
$418.15M |
$-140.11M |
-33.5% |
| 2017 |
$-0.88 |
$482.25M |
$-125.53M |
-26% |
| 2018 |
$-1.41 |
$654.7M |
$-222.69M |
-34% |
| 2019 |
$-0.38 |
$916.71M |
$-63.24M |
-6.9% |
| 2020 |
$3.37 |
$2.18B |
$613.67M |
28.2% |
| 2021 |
$-3.70 |
$1.57B |
$-674.47M |
-42.8% |
| 2022 |
$-3.30 |
$1.96B |
$-610.31M |
-31.1% |
